Veradigm Inc.

Informe acción OTCPK:MDRX

Capitalización de mercado: US$1.8b

Veradigm Dirección

Dirección controles de criterios 2/4

El CEO de Veradigm es Tom Langan, nombrado en May 2022, tiene una permanencia de 2.5 años. posee directamente un 0.2% de las acciones de la empresa, con un valor de $3.54M. La antigüedad media del equipo directivo y de la junta directiva es de 3.8 años y 6.5 años, respectivamente.

Información clave

Tom Langan

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.5yrs
Participación del CEO0.2%
Permanencia media de la dirección3.8yrs
Promedio de permanencia en la Junta Directiva6.5yrs

Actualizaciones recientes de la dirección

Recent updates

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Feb 28
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Nov 10
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Mar 06
Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Feb 13
Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 22
Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Dec 03
Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%

Sep 28

Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Sep 17
Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

Aug 24
Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Jul 31
We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Jun 15
Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

May 03
We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

CEO

Tom Langan (58 yo)

2.5yrs

Permanencia

Mr. Thomas J. Langan, also known as Tom, serves as CEO of Veradigm Inc. since June 7, 2024. He serves as President at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) since May 06, 2...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Tejal Vakharia
Senior VP of Marketing & Government Affairs4.4yrsUS$2.08m0.12%
$ 2.2m
Thomas Langan
President & Chief Commercial Officer and Interim CEO2.5yrssin datos0.20%
$ 3.5m
Leland Westerfield
Interim CFO and Principal Financial & Accounting Officerless than a yearsin datossin datos
Jenny Gelinas
Vice President of Investor Relations3.8yrssin datossin datos
Richard Elmore
Senior Vice President of Corporate Development & Strategy5.8yrssin datossin datos
Lisa Hammond
Senior VP & Chief Human Resources Officer3.5yrssin datos0.015%
$ 265.3k
John Sage
Senior Vice President of U.S. Hospitals & Health Systems Sales9.9yrssin datossin datos
Elliot Bryant
Senior VP & General Manager for Classic Client Solutions Business Unit4.3yrssin datossin datos
John Mayr
Senior Vice President of Global Client Delivery Organization2.8yrssin datossin datos
Alan Fowles
President of Allscripts International7.8yrssin datossin datos
Eric Jacobson
Senior VP & Corporate Secretaryno datasin datossin datos

3.8yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de MDRX se considera experimentado (3.8 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Jonathan Judge
Independent Director8.5yrsUS$301.00k0.091%
$ 1.6m
Carol Zierhoffer
Lead Independent Director4.3yrsUS$277.50k0.037%
$ 675.1k
David Stevens
Independent Director8.5yrsUS$281.50k0.032%
$ 569.7k
Kim Franks
Member of Advisory Boardno datasin datossin datos
Elizabeth Altman
Independent Director4.4yrsUS$277.50k0.033%
$ 603.5k
Susan Rodriguez
Director1.8yrssin datos0.012%
$ 224.5k
Jeanne Armstrong
Member of Advisory Boardno datasin datossin datos
Geoff Caplea
Member of Advisory Boardno datasin datossin datos
Laura Kohlhagen
Member of Advisory Boardno datasin datossin datos
Debbie McKay
Member of Advisory Boardno datasin datossin datos
Ramanujam Venugopalan
Member of Advisory Boardno datasin datossin datos

6.5yrs

Permanencia media

62.5yo

Promedio de edad

Junta con experiencia: La junta directiva de MDRX se considera experimentada (6.5 años de antigüedad promedio).